Longeveron (LGVN) Research & Development (2020 - 2026)
Longeveron's Research & Development was $3.19 million in Q2 2026, up 8.1% from $2.95 million a year earlier and up 37.7% from the prior quarter.
Powered by 
Analysis
Longeveron (LGVN) Research & Development (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Longeveron's Research & Development was $12.09 million through Jun 30, 2026, up 25.1% year-over-year; for FY2025, it was $12.04 million, up 48.0% from FY2024.
- Research & Development shows a five-year compound annual growth rate of 35.1% (FY2020 to FY2025).
- In earlier years, Research & Development was $8.14 million in FY2024 (-10.2%), $9.07 million in FY2023 (-3.2%), $9.37 million in FY2022 (+32.1%) and $7.09 million in FY2021 (+165.2%).
- Quarterly Research & Development has moved between $1.29 million (Q1 2022) and $3.85 million (Q3 2025) over five years.
- Compared with a year earlier, Research & Development was higher in six of the last eight quarters, with growth averaging 26.1%.
- The best year-over-year quarter for Research & Development over five years was Q3 2021 (growth of 250.1%); the worst was Q3 2023 (a decline of 37.7%).
- Per Business Quant data, LGVN's Research & Development in the three quarters before Q2 2026 was $2.32 million (Q1 2026), $2.72 million (Q4 2025) and $3.85 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Longeveron | 8.60 Mn | -31.21 Mn | 182,000.00 | 3.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.19 Mn |
| Mar 31, 2026 | 2.32 Mn |
| Dec 31, 2025 | 2.72 Mn |
| Sep 30, 2025 | 3.85 Mn |
| Jun 30, 2025 | 2.95 Mn |
| Mar 31, 2025 | 2.52 Mn |
| Dec 31, 2024 | 1.99 Mn |
| Sep 30, 2024 | 2.21 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Mar 31, 2024 | 2.22 Mn |
| Dec 31, 2023 | 2.16 Mn |
| Sep 30, 2023 | 1.84 Mn |
| Jun 30, 2023 | 2.29 Mn |
| Mar 31, 2023 | 2.78 Mn |
| Dec 31, 2022 | 3.26 Mn |
| Sep 30, 2022 | 2.96 Mn |
| Jun 30, 2022 | 1.72 Mn |
| Mar 31, 2022 | 1.29 Mn |
| Dec 31, 2021 | 1.73 Mn |
| Sep 30, 2021 | 2.05 Mn |
API Access
Longeveron Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=LGVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "LGVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=LGVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();